‘We Sent a Terrible Message’: Scientists Say Biden Jumped the Gun With Vaccine Booster Plan
Many experts say the evidence doesn’t justify widespread booster shots for adults.
Showing 81 - 100 of 116
-
-
At Urgent Care, He Got 5 Stitches and a Big Surprise: A Plastic Surgeon’s Bill for $1,040
The Biden administration is weighing how to treat urgent care clinics as part of broad regulations banning surprise, out-of-network medical bills. At the heart of the matter: What counts as an emergency?
-
Novavax’s Effort to Vaccinate the World, From Zero to Not Quite Warp Speed
Novavax is a vaccine company that, despite $2 billion in new federal and international funding, still hasn't come through with a licensed covid vaccine. It hopes it can still help to fight the global covid scourge, but will it deliver?
-
Unused Johnson & Johnson Covid Doses Are Piling Up as FDA Waits to See if Shelf Life Can Be Extended
As vaccine expiration dates loom, states with hundreds of thousands of doses on hand say demand is tanking and there’s no easy way to donate to other states or countries that might want them
By Rachana Pradhan and Christina Jewett -
Stark Racial Disparities Persist in Vaccinations, State-Level CDC Data Shows
Black Americans’ vaccination rates still trail all other groups, while Hispanics show improvement. Native Americans show the strongest rates nationally.
-
CVS and Walgreens Have Wasted More Vaccine Doses Than Most States Combined
More than 200,000 doses of covid vaccine have gone to waste since December, KHN has learned. Two national pharmacy chains account for most of it.
By Joshua Eaton and Rachana Pradhan -
‘Press 1 for English’: Vaccination Sign-Ups Prove Daunting for Speakers of Other Languages
In Virginia, if you called 1-877-VAX-IN-VA to register for a vaccine and wanted help in a language other than English or Spanish, the system might hang up on you.
-
Have a Case of a Covid Variant? No One Is Going to Tell You
As experts race to get an approved test for covid variants, officials are severely restricted from sharing information about the cases. That makes it harder to protect others.
-
After Billions of Dollars and Dozens of Wartime Declarations, Why Are Vaccines Still in Short Supply?
The Trump and Biden administrations both imposed wartime production requirements. But industry experts say the vast quantities of raw materials and specialty equipment needed for billions of newfangled vaccines have required herculean logistical efforts.
By Rachana Pradhan and Arthur Allen -
Huge Gaps in Vaccine Data Make It Next to Impossible to Know Who Got the Shots
Details about race, ethnicity and occupation are often missing as data collected nationally is scattered across scores of digital systems that don’t connect. And the CDC doesn’t require vaccinators to report occupations of recipients, even though the order in which people get shots largely depends on their job.
By Rachana Pradhan and Fred Schulte -
Delicate Covid Vaccines Slow Rollout — Leading to Shots Given Out of Turn or, Worse, Wasted
“Thaw. Rest 15 minutes. Do not shake. Do not refreeze.”Do not shake. Do not refreeze.” Moderna’s vaccine comes with complicated instructions. And both available vaccines are good for only six hours once the vial is open. So at day’s end, health workers are left to either throw out precious doses or get shots into any arm that’s available.
-
Inside the First Chaotic Days of the Effort to Vaccinate America
After missteps in Washington, each state and county is left to juggle where to send vaccines first and how to get them to each nursing home, hospital local health department and even school.
-
In Becerra, an HHS Nominee With Political Skill But No Front-Line Health Experience
Despite his lack of front-line experience, Democrats see the California attorney general as an important ally to shepherd a progressive agenda on the Affordable Care Act, Medicaid, reproductive health services and immigration.
-
How Pharma Money Colors Operation Warp Speed’s Quest to Defeat COVID
A Trump administration maneuver allows executives who are leading the federal effort to keep investments in drug companies that would benefit from the pandemic response.
-
Nursing Homes Still See Dangerously Long Waits for COVID Test Results
The Trump administration hailed rapid tests as the way to halt COVID’s spread in nursing homes. A KHN analysis of federal data shows they’re not being used, as questions linger about accuracy and best practices.
-
As Nation Awaits Vaccine, Biden Is Under Pressure to Name New FDA Chief ASAP
It typically takes months to install new leadership, but with COVID deaths set to surge through the winter, many Democrats say Biden doesn’t have that sort of time.
-
Verily’s COVID Testing Program Halted in San Francisco and Oakland
Health officials in San Francisco and Alameda counties have cut ties with Verily’s state-funded COVID testing sites amid concerns about data collection and privacy.
By Jenny Gold and Rachana Pradhan -
Inside the Flawed White House Testing Scheme That Did Not Protect Trump
President Trump relied heavily on testing as protection against COVID exposure, eschewing masks and social distancing.
-
These Secret Safety Panels Will Pick the COVID Vaccine Winners
Data and safety monitoring boards work under a cloak of secrecy meant to prevent undue influence by stakeholders, such as companies or the government. In the Trump era, some worry the anonymity could actually invite it.
-
It’s Not Just Insulin: Lawmakers Focus on Price of One Drug, While Others Rise Too
While insulin is the poster child for outrageous prescription costs, patients are paying ever more to treat depression, asthma, HIV, cholesterol and more. And the pandemic has overtaken efforts to force the issue in Congress.
Sign Up For Our Newsletter
Stay informed by signing up for the Morning Briefing and other emails: